Total resting periods, locomotor time 2

The total number of resting periods in time2. A resting period is defined as a period of inactivity greater than or equal to 1 second.

Tags: Behavior · Locomotion

Project: u01_suzanne_mitchell

1 loci · 1 genes with independent associations · 1 total associated genes

Significant Loci

# Chr Start pos End pos # assoc genes # joint models Best TWAS P Best GWAS P Cond GWAS P Joint genes
1 9 24497174 25018277 1 1 9.13e-09 1.14e-02 1e+00 Rims1

Pleiotropic Associations

Trait Chi2 ratio # genes+ # genes++ % genes++ Corr Corr P Genes
Right kidney weight 1.91 1 0 0 0 1e+00 Rims1
Liver weight, right 3.23 1 0 0 0 1e+00 Rims1
Indifference point function ln k 3.18 1 0 0 0 1e+00 Rims1
Indifference point function log k 3.18 1 0 0 0 1e+00 Rims1
Delay discounting water rate 12 sec 2.71 1 0 0 0 1e+00 Rims1
Delay discounting water rate 24 sec 3.19 1 0 0 0 1e+00 Rims1
Light reinforcement 1 2.11 1 0 0 0 1e+00 Rims1
Light reinforcement 2 7.69 1 0 0 0 1e+00 Rims1
Conditioned reinforcement - inactives 5.55 1 0 0 0 1e+00 Rims1
Intermitt. access day 1 inactive lever presses 15.13 1 0 0 0 1e+00 Rims1
Intermitt. access day 15 inactive lever presses 7.68 1 0 0 0 1e+00 Rims1
Intermitt. access escalation Index 4.62 1 0 0 0 1e+00 Rims1
Intermittent access total infusions 4.68 1 0 0 0 1e+00 Rims1
Lifetime Intake 4.54 1 0 0 0 1e+00 Rims1
Incentive Sensitization - Responses 8.42 1 0 0 0 1e+00 Rims1
Incentive Sensitization - Breakpoint 6.3 1 0 0 0 1e+00 Rims1
Progressive ratio test 1 active lever presses 11.71 1 0 0 0 1e+00 Rims1
Progressive ratio test 1 breakpoint 14.08 1 0 0 0 1e+00 Rims1
Progressive ratio test 2 active lever presses 14.22 1 0 0 0 1e+00 Rims1
Progressive ratio test 2 breakpoint 16.36 1 0 0 0 1e+00 Rims1
Short access day 10 total inactive lever presses 29.49 1 1 100 0 1e+00 Rims1
Short access total infusions 5.45 1 0 0 0 1e+00 Rims1
Short access day 1 locomotion 3.69 1 0 0 0 1e+00 Rims1
One hour access (0.3 mA shock) 4.85 1 0 0 0 1e+00 Rims1
Locomotion velocity, session 1 4.12 1 0 0 0 1e+00 Rims1
Locomotion velocity, session 2 3.43 1 0 0 0 1e+00 Rims1
Locomotion velocity, session 3 6.63 1 0 0 0 1e+00 Rims1
Bone: tissue strength 4.34 1 0 0 0 1e+00 Rims1
Distance traveled before self-admin 5.8 1 0 0 0 1e+00 Rims1
Distance traveled after self-admin 4.99 1 0 0 0 1e+00 Rims1
Diff in mean of infusions in LGA sessions 3.99 1 0 0 0 1e+00 Rims1
Extinction: sum of active levers before priming 27.4 1 1 100 0 1e+00 Rims1
Delta distance traveled before/after self-admin 12.16 1 0 0 0 1e+00 Rims1
Delta ambulatory time before/after self-admin 5.33 1 0 0 0 1e+00 Rims1
Time in closed arm after self-admin 7.54 1 0 0 0 1e+00 Rims1
Time to tail flick, vehicle, before self-admin 9.4 1 0 0 0 1e+00 Rims1
Time >=10cm from walls, locomotor time 1 29.01 1 1 100 0 1e+00 Rims1
Bouts of movement, locomotor time 1 5.95 1 0 0 0 1e+00 Rims1
Total resting periods, locomotor time 1 6.96 1 0 0 0 1e+00 Rims1
Vertical activity count, locomotor time 1 6.12 1 0 0 0 1e+00 Rims1
Bouts of movement, locomotor time 2 26.45 1 1 100 0 1e+00 Rims1
Rest time, locomotor task time 2 4.5 1 0 0 0 1e+00 Rims1
Distance moved, locomotor task time 2 3.5 1 0 0 0 1e+00 Rims1
Locomotion in novel chamber post-restriction 5.15 1 0 0 0 1e+00 Rims1
Fe content in liver 3.29 1 0 0 0 1e+00 Rims1

Associations by panel

Tissue RNA modality # hits % hits/tests Avg chisq
Adipose alternative polyA 0 0 1.02
Adipose alternative TSS 0 0 1.1
Adipose gene expression 0 0 1.03
Adipose isoform ratio 0 0 1.07
Adipose intron excision ratio 0 0 1.2
Adipose mRNA stability 0 0 1.03
BLA alternative polyA 0 0 1.01
BLA alternative TSS 0 0 1.19
BLA gene expression 0 0 1.06
BLA isoform ratio 0 0 1.08
BLA intron excision ratio 0 0 1.12
BLA mRNA stability 0 0 1.03
Brain alternative polyA 0 0 1.15
Brain alternative TSS 0 0 1.13
Brain gene expression 0 0 1.07
Brain isoform ratio 0 0 1.03
Brain intron excision ratio 0 0 1.13
Brain mRNA stability 0 0 1
Eye alternative polyA 0 0 1.27
Eye alternative TSS 0 0 1.18
Eye gene expression 0 0 1.08
Eye isoform ratio 0 0 1.24
Eye intron excision ratio 0 0 1.25
Eye mRNA stability 0 0 1.05
IL alternative polyA 0 0 1.05
IL alternative TSS 0 0 1.18
IL gene expression 0 0 1.08
IL isoform ratio 0 0 1.14
IL intron excision ratio 0 0 1.02
IL mRNA stability 0 0 1.05
LHb alternative polyA 0 0 1.02
LHb alternative TSS 0 0 1.12
LHb gene expression 0 0 1.08
LHb isoform ratio 0 0 1.06
LHb intron excision ratio 0 0 1.17
LHb mRNA stability 0 0 1.01
Liver alternative polyA 0 0 0.98
Liver alternative TSS 0 0 1.03
Liver gene expression 0 0 1.04
Liver isoform ratio 0 0 1.01
Liver intron excision ratio 0 0 1.05
Liver mRNA stability 0 0 0.97
NAcc alternative polyA 0 0 1.08
NAcc alternative TSS 0 0 1.15
NAcc gene expression 1 0 1.08
NAcc isoform ratio 0 0 1.11
NAcc intron excision ratio 0 0 1.13
NAcc mRNA stability 0 0 1.11
OFC alternative polyA 0 0 1.09
OFC alternative TSS 0 0 1.17
OFC gene expression 0 0 1.11
OFC isoform ratio 0 0 1.09
OFC intron excision ratio 0 0 1.07
OFC mRNA stability 0 0 1.12
PL alternative polyA 0 0 1.03
PL alternative TSS 0 0 1.09
PL gene expression 0 0 1.07
PL isoform ratio 0 0 1
PL intron excision ratio 0 0 1.11
PL mRNA stability 0 0 1.05